Your prediction
Atea ASA Stock
The Atea ASA stock is trending slightly upwards today, with an increase of €0.020 (0.130%) compared to yesterday's price.
Pros and Cons of Atea ASA in the next few years
Pros
?
S********** s********
?
W********* I********* f** t** n*** y****
?
C******** o* t** e**********
Cons
?
G***** c******* t* c**********
?
M***** P*******
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Atea ASA vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Atea ASA | 0.130% | -1.646% | 1.835% | 30.151% | 17.727% | 29.716% | -5.128% |
| ELF Beauty Inc | -1.580% | 5.831% | 12.181% | -21.234% | 10.035% | -36.085% | - |
| Natural Grocers By Vit. Cot. | 0.000% | -0.704% | -0.704% | -9.032% | 31.776% | 138.983% | 200.000% |
| Designer Brands Inc. | 0.000% | 5.556% | 19.247% | 133.607% | -12.977% | -38.378% | -48.649% |
News
Atea Pharmaceuticals Q1 Earnings Call Highlights
Atea Pharmaceuticals (NASDAQ:AVIR) said it remains on track for two key Phase 3 hepatitis C readouts in 2026 while advancing a newer hepatitis E program aimed at immunocompromised patients with no
